Literature DB >> 33678230

Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach.

Patti E Gravitt1, Michelle I Silver2, Heather M Hussey3, Silvina Arrossi4, Megan Huchko5, Jose Jeronimo6, Sharon Kapambwe7, Somesh Kumar8, Graciela Meza9, Laura Nervi10, Valerie A Paz-Soldan11, Yin Ling Woo12.   

Abstract

The World Health Organization (WHO) is leading a call to action to eliminate cervical cancer by the end of the century through global implementation of two effective evidence-based preventive interventions: HPV vaccination and cervical screening and management (CSM). Models estimate that without intervention, over the next 50 years 12.2 million new cases of cervical cancer will occur, nearly 60% of which are preventable only through CSM. Given that more than 80% of the cervical cancer occurs in low- and middle-income countries (LMICs), scaling up sustainable CSM programs in these countries is a top priority for achieving the global elimination goals. Multiple technologies have been developed and validated to meet this need. Now it is critical to identify strategies to implement these technologies into complex, adaptive health care delivery systems. As part of the coordinated cervical cancer elimination effort, we applied a systems thinking lens to reflect on our experiences with implementation of HPV-based CSM programs using the WHO health systems framework. While many common health system barriers were identified, the effectiveness of implementation strategies to address them was context dependent; often reflecting differences in stakeholder's belief in the quality of the evidence supporting a CSM algorithm, the appropriateness of the evidence and algorithm to context, and the 'implementability' of the algorithm under realistic assessments of resource availability and constraints. A structured planning process, with early and broad stakeholder engagement, will ensure that shared-decisions in CSM implementation are appropriately aligned with the culture, values, and resource realities of the setting.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33678230     DOI: 10.1016/j.ypmed.2020.106322

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.637


  3 in total

1.  Changing the paradigm of cervical cancer prevention through introduction of HPV-testing: evaluation of the implementation process of the Jujuy Demonstration Project in Argentina.

Authors:  Silvina Arrossi; Melisa Paolino; Rosa Laudi; Laura Thouyaret
Journal:  Ecancermedicalscience       Date:  2021-03-04

2.  Planning for resilience in screening operations using discrete event simulation modeling: example of HPV testing in Peru.

Authors:  Anne F Rositch; Aditya Singh; Nadia Lahrichi; Valerie A Paz-Soldan; Anna Kohler-Smith; Patti Gravitt; Erica Gralla
Journal:  Implement Sci Commun       Date:  2022-06-17

Review 3.  Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.

Authors:  Laia Bruni; Beatriz Serrano; Esther Roura; Laia Alemany; Melanie Cowan; Rolando Herrero; Mario Poljak; Raul Murillo; Nathalie Broutet; Leanne M Riley; Silvia de Sanjose
Journal:  Lancet Glob Health       Date:  2022-08       Impact factor: 38.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.